Anthracyclines, commonly used for various cancers, are associated with cardiomyopathy and primary cancer treatment-induced arrhythmias.
Anthracyclines are commonly used in the treatment of breast cancer, acute leukemia, lymphomas, and childhood solid tumors. Cardiomyopathy is the most common cardiac toxicity of anthracyclines, but they can often cause primary CTIA,
Buza et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: